Table 5.

The extent of the staining of IFX efficacy-predicting proteins in colonic biopsies from UC patients.

Variable	Staining extent score					Mean score	p-value a
	0 (n, %)	1 (n, %)	2 (n, %)	3 (n, %)	4 (n, %)
CDX2							0.757
Responders	13 (76.5%)	4 (23.5%)	0	0	0	0.24
Non-responders	5 (71.4%)	1 (14.3%)	1 (14.3%)	0	0	0.34
HSD11B2							0.534
Responders	1 (5.9%)	6 (35.3%)	5 (29.4%)	4 (23.5%)	1 (5.9%)	1.88
Non-responders	0	4 (57.1%)	2 (28.6%)	1 (14.3%)	0	1.57
CHP2							0.209
Responders	0	3 (17.6%)	4 (23.5%)	5 (29.4%)	5 (29.4%)	2.71
Non-responders	0	0	6 (85.7%)	1 (14.3%)	0	2.14
RANK							0.114
Responders	0	0	6 (35.3%)	5 (29.4%)	6 (35.3%)	3.00
Non-responders	0	1 (14.3%)	3 (42.9%)	3 (42.9%)	0	2.29
NOX4							0.234
Responders	0	0	12 (70.6%)	5 (29.4%)	0	2.29
Non-responders	0	0	3 (42.9%)	3 (42.9%)	1 (14.3%)	2.71
VDR							0.065
Responders	0	5 (29.4%)	8 (47.1%)	3 (17.6%)	1 (5.9%)	2.00
Non-responders	0	5 (71.4%)	2 (28.6%)	0	0	1.29

^aA Mann–Whitney U test was used for the analysis.